4
Shared Docs
4
Same-Page
4 / 4
Mentions
iative online discussion on 'Strengthening U.S. Manufacturing' — 'Strengthening U.S. Manufacturing: Enhancing Resilience' online discussion hosted by the Hudson Institute and the Manufacturing Policy Initiative at Indiana University, with discussion on the role the U.S. govt can play to enhance resilience of the manu
ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human
tive online discussion on 'Strengthening U.S. Manufacturing' - 'Strengthening U.S. Manufacturing: Enhancing Resilience' online discussion hosted by the Hudson Institute and the Manufacturing Policy Initiative at Indiana University, with discussion on the role the U.S. govt can play to enhance resilience of the manuf
ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
tive online discussion on 'Strengthening U.S. Manufacturing' - 'Strengthening U.S. Manufacturing: Enhancing Resilience' online discussion hosted by the Hudson Institute and the Manufacturing Policy Initiative at Indiana University, with discussion on the role the U.S. govt can play to enhance resilience of the manu
ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
tive online discussion on 'Strengthening U.S. Manufacturing' - 'Strengthening U.S. Manufacturing: Enhancing Resilience' online discussion hosted by the Hudson Institute and the Manufacturing Policy Initiative at Indiana University, with discussion on the role the U.S. govt can play to enhance resilience of the manu
ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
Entities connected to both the Hudson Institute and Amgen

Donald Trump
PERSON
Jeffrey Epstein
PERSON
United States
LOCATION
Michael Jackson
PERSON
Bill Clinton
PERSON
Barack Obama
PERSON
Marc Rich
PERSON
Joe Biden
PERSON
George Mitchell
PERSON
Philadelphia
LOCATION
Michael Cohen
PERSON
Virginia Giuffre
PERSONEmmy Taylor
PERSON
Stephen Hawking
PERSON
Prince Andrew
PERSON
Julie K. Brown
PERSON
Eric Trump
PERSON
Bloomberg L.P.
ORGANIZATIONLeon Black
PERSON
Atlanta
LOCATION